BUY Ozempic (Semaglutide)
- glp1ussolution
- 1 day ago
- 2 min read
Ozempic is a prescription drug used to lower blood sugar levels for type two diabetic patients, along with diet and exercise. It works by binding to GLP-1 receptors which stimulates insulin release from the pancreas when you need insulin, it also helps to reduce the amount of sugar released by your liver and slows down food leaving your stomach. The combination of these effects helps to lower your A1C and blood sugar levels, and may also help reduce your appetite. Ozempic is also used for diabetic patients who already have cardiovascular disease, to help lower the risk of major cardiovascular events such as heart attack or stroke.
Generic name: semaglutide
Brand names: Ozempic, Wegovy, Rybelsus
Dosage form: subcutaneous injection, tablet
Drug class: GLP-1 Agonists (Incretin Mimetics)
Semaglutide is a prescription medicine used for weight loss, type 2 diabetes management, and to reduce the risk of chronic kidney disease and major cardiovascular events in certain adult patients.
Semaglutide is a GLP-1 receptor agonist that behaves like the GLP-1 hormone that is naturally released after eating. Semaglutide works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released.
Semaglutide is available as a weekly injection (Ozempic, Wegovy) or a daily oral tablet (Rybelsus).
Semaglutide brand names are Ozempic, Rybelus, and Wegovy, all made by Novo Nordisk. Each brand is FDA-approved for different conditions. Semaglutide FDA approval was first granted on December 5, 2017, for the brand Ozempic.
Semaglutide FDA-approved uses for each brand are Ozempic (type 2 diabetes, cardiovascular event risks, chronic kidney disease), Wegovy (weight management, cardiovascular event risks), and Rybelsus (type 2 diabetes).
Ozempic (semaglutide) injection
Ozempic is used to treat type 2 diabetes in adults to help control blood sugar levels used together with diet and exercise,
Used for reducing major cardiovascular event risks (such as heart attack, stroke, or death) in adults with type 2 diabetes with known heart disease
Used to reduce the risk of kidney function decline, kidney failure, and death due to cardiovascular disease, in adults with chronic kidney disease (CKD) and type 2 diabetes
Injection is given 1 time a week under the skin of the stomach (belly), the thigh, or the upper arm, using an autoinjector (pen).
GLP-1 solutions include:
1. Semaglutide (Ozempic, Wegovy)
2. Liraglutide (Saxenda, Victoza)
3. Tirzepatide (Mounjaro)
These medications work by:
1. Regulating appetite
2. Slowing gastric emptying
3. Reducing glucose production
Fitness enthusiast | Health advocate | Life lover 💪🌟!
Passionate about living a balanced lifestyle, fueling my body with nutritious food, and pushing my limits. Always looking for new challenges and ways to improve my well-being. Let's connect and support each other on our wellness journeys!
Comments